RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL I...

Por F. A. Khabirov, T. I. Khaibullin, E. V. Granatov, N. N. Babicheva, L. A. Aver’yanova, S. R. Shakirzyanova
Publicado em 2017-01-01